Frontiers in Bioengineering and Biotechnology, 2022 · DOI: 10.3389/fbioe.2022.997877 · Published: October 13, 2022
This study introduces a new cervical subtotal discectomy prosthesis (CSDP) designed to replace damaged cervical discs while preserving part of the vertebral endplate. The CSDP was tested for biocompatibility and osseointegration in cell cultures and mice before being implanted in monkeys to assess its safety and biomechanical stability. Results showed the CSDP exhibited excellent safety, osseointegration, and biomechanical stability in the monkey model, suggesting it could be a promising alternative for treating cervical disc diseases.
The CSDP offers a potential alternative to traditional cervical interbody fusion surgery, aiming to preserve cervical mobility and reduce adjacent segment disease.
The hemiarthroplasty-like design of the CSDP, retaining the lower endplate, and the ellipsoid-in-socket articulation may reduce complications associated with total disc replacement prostheses.
The successful validation in a non-human primate model supports the potential for future clinical trials to evaluate the effectiveness and safety of CSDP in human patients with cervical disc diseases.